Free Trial

Innospec (NASDAQ:IOSP) Reaches New 12-Month Low - Here's What Happened

Innospec logo with Basic Materials background
Remove Ads

Shares of Innospec Inc. (NASDAQ:IOSP - Get Free Report) hit a new 52-week low during trading on Monday . The company traded as low as $99.21 and last traded at $99.26, with a volume of 134611 shares trading hands. The stock had previously closed at $103.41.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Innospec from a "hold" rating to a "buy" rating in a research report on Thursday.

View Our Latest Stock Analysis on Innospec

Innospec Stock Up 1.1 %

The company has a market capitalization of $2.51 billion, a P/E ratio of 70.86 and a beta of 1.09. The business has a 50 day simple moving average of $109.09 and a 200-day simple moving average of $111.99.

Innospec (NASDAQ:IOSP - Get Free Report) last posted its earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.05. Innospec had a net margin of 1.93% and a return on equity of 12.27%. The firm had revenue of $466.80 million during the quarter, compared to analyst estimates of $447.43 million. Equities analysts forecast that Innospec Inc. will post 6.18 EPS for the current fiscal year.

Remove Ads

Insider Buying and Selling

In related news, SVP Corbin Barnes sold 598 shares of the business's stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $103.06, for a total transaction of $61,629.88. Following the sale, the senior vice president now owns 8,051 shares of the company's stock, valued at $829,736.06. The trade was a 6.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Milton C. Blackmore sold 652 shares of the stock in a transaction on Friday, February 21st. The shares were sold at an average price of $103.30, for a total value of $67,351.60. Following the transaction, the director now directly owns 8,376 shares of the company's stock, valued at approximately $865,240.80. The trade was a 7.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,696 shares of company stock valued at $794,853 in the last three months. 1.52% of the stock is currently owned by corporate insiders.

Institutional Trading of Innospec

Several institutional investors have recently modified their holdings of the company. US Bancorp DE raised its position in Innospec by 323.6% in the third quarter. US Bancorp DE now owns 5,490 shares of the specialty chemicals company's stock worth $621,000 after acquiring an additional 4,194 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Innospec by 3.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 336,522 shares of the specialty chemicals company's stock valued at $38,057,000 after purchasing an additional 11,479 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Innospec by 24.6% during the third quarter. JPMorgan Chase & Co. now owns 266,688 shares of the specialty chemicals company's stock worth $30,160,000 after buying an additional 52,640 shares in the last quarter. HighTower Advisors LLC grew its position in Innospec by 5.2% in the third quarter. HighTower Advisors LLC now owns 3,103 shares of the specialty chemicals company's stock worth $350,000 after buying an additional 154 shares during the last quarter. Finally, Citigroup Inc. increased its holdings in shares of Innospec by 46.1% in the third quarter. Citigroup Inc. now owns 32,193 shares of the specialty chemicals company's stock valued at $3,641,000 after buying an additional 10,162 shares in the last quarter. Institutional investors and hedge funds own 96.64% of the company's stock.

Innospec Company Profile

(Get Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Recommended Stories

Should You Invest $1,000 in Innospec Right Now?

Before you consider Innospec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.

While Innospec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!
Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads